<DOC>
	<DOCNO>NCT02552251</DOCNO>
	<brief_summary>Congenital adrenal hyperplasia ( CAH ) result deficiency key enzyme biosynthesis cortisol , mainly 21-hydroxylase , result classic form neonatal salt loss syndrome / virilization syndrome girl . The treatment disorder adulthood involve administer steroidal compound aim substitute gluco- mineralocorticoid deficit one hand , effectively curb adrenal hyperplasia adrenal androgen pathway girl . The term glucocorticoid treatment clearly codify base several steroidal compound various protocol . The advantage term adrenal suppression disadvantage - include bone metabolic - different treatment clearly establish literature . The main objective study compare among adult HCS classical form impact hormonal parameter adrenal suppression glucocorticoid 3 type treatment administer equivalent dose accord usual procedure . The secondary objective compare patient impact different drug treatment several metabolic bone parameter . The study include 40 adult patient bear HCS classical form include 3 treatment sequence eight week , administer sequentially random order random accord know equivalence hydrocortisone , prednisone ( CORTANCYL ) dexamethasone ( DECTANCYL ) . Randomization stratify base previous DMARDs investigation may different different patient , know France hydrocortisone dexamethasone use mainly treatment congenital adrenal hyperplasia . The judging criterion : ) criteria adrenal hormone suppression : plasma level testosterone , androstenedione , 17 OHP , ACTH diurnal variation 17 OH progesterone salivary ii ) criterion metabolic impact glucocorticoid : plasma glucose level , blood lipid , insulin sensitivity index HOMA-R calculate glucose insulin , iii ) criteria bone impact glucocorticoid : plasma CTX bone resorption bone alkaline phosphatase P1NP bone formation iv ) living quality criterion evaluate PGWB Questionnaire ( Psychological General Well-Being ) . The duration study period 24 month .</brief_summary>
	<brief_title>COrticosteroid Congenital Adrenal Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Adrenal Hyperplasia , Congenital</mesh_term>
	<mesh_term>Adrenogenital Syndrome</mesh_term>
	<mesh_term>Adrenocortical Hyperfunction</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Pubescent woman 18 genital activity ( premenopausal ) Suffering congenital adrenal hyperplasia classical form salt loss pure virilize Patients present sign congenital adrenal hyperplasia classical form ( salt waste syndrome / neonatal masculinization ) elevation 17 OH progesterone diagnosis enzyme block 21 hydroxylase . Patients currently treat : 1 2 Oral compound glucocorticoid replacement suppressive therapy + 1 mineralocorticoid necessary effective control substitution + possibly estrogenprogestin pill . Liver disease , kidney , bone , diabetes , severe dyslipidemia , pregnancy Postmenopausal woman , age 55 year Concomitant therapy : glucocorticoid supraphysiological dos indication , bisphosphonates , vitamin D , oral antidiabetic agent insulin , lipid lower agent ( eg inflammatory disease , asthma , systemic disease ... .. ) . participation subject another biomedical research protocol study Inability submit medical monitoring study geographical , social psychological . Severe calorie diet plan carry study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>